… generates brain dysfunction, but neuronal stem cells in the … Regression of renal disease with
remodeling of glomerular … the way we think of normal renal cell biology or pathophysiology (…

… of renal dysfunction in cisplatin-induced renal dysfunction, 35 we selected LA as the drug to
attenuate the renal dysfunction. … 7B, the effect of the hydrogel/LA scaffold on cell viability was …

… endothelial cells, vascular smooth muscle cells, … stem cell therapy cannot be readily attributed
to stem cell differentiation and proliferation, but to the paracrine effects of transplanted cells.…

… Fusion of bone marrow-derived cells with renal tubules contributes to renal dysfunction in
diabetic nephropathy. The FASEB journal: official publication of the Federation of American …

… Biochemical analyses of markers of renal dysfunction found a significant increment in
creatinine and blood urea nitrogen (BUN) plasma levels in mice subjected to PNx and sacrificed 4 …

… dysfunction and delayed renal recovery [11]. In non-dialytic setting of ARF, the standard
recommendation for protein intake is in the range of 1.5 g/kg per day. In patients on CRRT, in …

… stem cells to differentiate into renal cell lineages, 12 – 16 but current data mainly support a
paracrine action of BM stem cells in … The capacity of MSC to ameliorate renal dysfunction and …

… Accordingly, TNF-α inhibitors can ameliorate renal dysfunction and reduce the structural
damage caused by cisplatin, and inhibition of TNF-α more effectively reduce cisplatin-induced …

… CKD, we have investigated HSC homeostasis in a mouse model for chronic renal failure (CRF).
We demonstrate that chronic renal failure (CRF) leads to a significant decrease in HSC …

… We hypothesized that MSC-secreted factors have a therapeutic rescue function by supporting
renal repair and hence renal function and thus reduce progression of established CKD. …